116 related articles for article (PubMed ID: 38606092)
1. Corrigendum: Cancer data quality and harmonization in Europe: The experience of the BENCHISTA Project - International Benchmarking of Childhood Cancer Survival by Stage.
Lopez-Cortes A; Didonè F; Botta L; Hjalgrim LL; Jakab Z; Cañete Nieto A; Stiller C; Zeller B; Gatta G; Pritchard-Jones K;
Front Oncol; 2024; 14():1397101. PubMed ID: 38606092
[TBL] [Abstract][Full Text] [Related]
2. Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project - international benchmarking of childhood cancer survival by stage.
Lopez-Cortes A; Didonè F; Botta L; Hjalgrim LL; Jakab Z; Canete Nieto A; Stiller C; Zeller B; Gatta G; Pritchard-Jones K;
Front Oncol; 2023; 13():1232451. PubMed ID: 37675230
[TBL] [Abstract][Full Text] [Related]
3. International benchmarking of childhood cancer survival by stage at diagnosis: The BENCHISTA project protocol.
Botta L; Gatta G; Didonè F; Lopez Cortes A; Pritchard-Jones K;
PLoS One; 2022; 17(11):e0276997. PubMed ID: 36327231
[TBL] [Abstract][Full Text] [Related]
4. Assessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry study.
Aitken JF; Youlden DR; Moore AS; Baade PD; Ward LJ; Thursfield VJ; Valery PC; Green AC; Gupta S; Frazier AL
Lancet Child Adolesc Health; 2018 Mar; 2(3):173-179. PubMed ID: 30169253
[TBL] [Abstract][Full Text] [Related]
5. Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership.
Walters S; Maringe C; Butler J; Brierley JD; Rachet B; Coleman MP
Int J Cancer; 2013 Feb; 132(3):676-85. PubMed ID: 22623157
[TBL] [Abstract][Full Text] [Related]
6. An application of the Toronto Childhood Cancer Stage Guidelines in three population-based cancer registries: The case of central nervous tumors.
Sacerdote C; Mosso ML; Alessi D; Merletti F; Tagliabue G; D'Agostino A; Fabiano S; Savoia F; Piga P; Sessa M; Vetrano F; Gatta G; Maule M
Pediatr Blood Cancer; 2020 Jun; 67(6):e28303. PubMed ID: 32301558
[TBL] [Abstract][Full Text] [Related]
7. Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.
Cabasag CJ; Arnold M; Piñeros M; Morgan E; Brierley J; Hofferkamp J; Kehoe S; Butler J; Bucher O; Bray F; Soerjomataram I; Parkin DM
Int J Cancer; 2021 Sep; 149(6):1239-1246. PubMed ID: 33990959
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis.
Yang Y; Wang J; Wang W; Zhang T; Zhao J; Wang Y; Li Y; Wang L; Bi N
Front Oncol; 2022; 12():1007862. PubMed ID: 36091135
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum: LASSO-derived prognostic model predicts cancer-specific survival in advanced pancreatic ductal adenocarcinoma over 50 years of age: a retrospective study of SEER database research.
Feng Y; Yang J; Duan W; Cai Y; Liu X; Peng Y
Front Oncol; 2024; 14():1370998. PubMed ID: 38384803
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Survival Outcomes After Breast-Conserving Therapy Compared With Mastectomy for Patients With Early-Stage Invasive Micropapillary Carcinoma of the Breast: A SEER Population-Based Study.
Wang S; Zhang Y; Yin F; Wang X; Yang Z
Front Oncol; 2022; 12():890018. PubMed ID: 35494049
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Decreased Survival of Invasive Ductal Breast Cancer Patients With Two Macrometastatic Lymph Nodes Among Few Resected Ones: Should Current Sentinel-Lymph-Node Guidelines Be Revised?
Luz FAC; Araújo RA; Silva MJB
Front Oncol; 2021; 11():755438. PubMed ID: 34552883
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum: Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis.
Yi J; Liu Z; Wang L; Zhang X; Pi L; Zhou C; Mu H
Front Oncol; 2022; 12():916310. PubMed ID: 35574297
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis.
Wang W; Huang G; Lin H; Ren L; Fu L; Mao X
Front Oncol; 2023; 13():1216134. PubMed ID: 38264752
[TBL] [Abstract][Full Text] [Related]
14. Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000-2017.
Youlden DR; Baade PD; Frazier AL; Gupta S; Gottardo NG; Moore AS; Aitken JF
Acta Oncol; 2023 Oct; 62(10):1256-1264. PubMed ID: 37647245
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: The presence of autoantibodies is associated with improved overall survival in lung cancer patients.
Jing K; Zhao H; Cai J; Chen L; Zheng P; Ouyang L; Li G; Wang R
Front Oncol; 2023; 13():1353702. PubMed ID: 38192623
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer.
Jia Y; Quan S; Ren J; Wu H; Liu A; Gao Y; Hao F; Yang Z; Zhang T; Hu H
Front Oncol; 2022; 12():1125641. PubMed ID: 36713503
[TBL] [Abstract][Full Text] [Related]
17. National benchmarking between the Nordic countries on the quality of care.
Mainz J; Hjulsager M; Og MT; Burgaard J
J Surg Oncol; 2009 Jun; 99(8):505-7. PubMed ID: 19072992
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Early Onset Colon Adenocarcinoma.
Jin H; Feng Y; Guo K; Ruan S
Front Oncol; 2021; 11():793652. PubMed ID: 35004318
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: The Association of Aberrant Expression of FGF1 and mTOR-S6K1 in Colorectal Cancer.
Duan T; Zhou D; Yao Y; Shao X
Front Oncol; 2021; 11():792453. PubMed ID: 34760712
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer.
Zheng Y; Zhong G; Yu K; Lei K; Yang Q
Front Oncol; 2020; 10():482. PubMed ID: 32328463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
